Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Another Big Verdict in Talc Case Against J&J

May 4, 2016 8:46 am | by Jim Salter, Associated Press | News | Comments

The medical community hasn't reached a consensus on talc as a possible carcinogen.


Research Points to New Pancreatic Cancer Treatment

May 4, 2016 8:46 am | by Purdue University | News | Comments

Researchers have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis.


Faster, Cheaper Way to Produce New Antibiotics

May 4, 2016 8:42 am | by University of Bristol | News | Comments

With resistance growing to existing antibiotics, there is a vital and urgent need for the discovery and development of new antibiotics that are cost effective.


Herbal Remedies Are an Overlooked Global Health Hazard

May 4, 2016 8:30 am | by Baylor College of Medicine | News | Comments

Millions of people around the world use herbal health remedies, following a tradition that began millennia ago.


Side Effects of Statins Investigated in New £1M Trial

May 4, 2016 7:30 am | by London School of Hygiene & Tropical Medicine | News | Comments

Many patients stop taking statins due to less severe symptoms, such as muscle pain or fatigue.


Investigational Compound Shows Promise Against Melanoma, Lymphoma

May 3, 2016 3:00 pm | by UNC Chapel Hill | News | Comments

The specific mutation of EZH2 is a relatively common event in diverse cancers.


Asthma Linked to DNA Damage

May 3, 2016 2:00 pm | by Anne Trafton, MIT News Office | News | Comments

The research team focused on dust-mite-induced allergies because dust mites are ubiquitous and thrive in warm, humid climates.


Pfizer Tops Street 1Q Forecasts on Higher Sales, Lower Taxes

May 3, 2016 1:30 pm | by Linda A. Johnson, AP Business Writer | News | Comments

The company raised its 2016 financial forecasts, citing the strong quarter and an improved business outlook.


Ebola Vaccine: Promising Phase 1 Trials

May 3, 2016 1:00 pm | by German Center for Infection Research | News | Comments

Across the four locations, a total of 158 healthy volunteers were vaccinated with increasing doses of the potential vaccine


Gene Therapy May Reverse Degenerative Eye Disease Long Term

May 3, 2016 10:53 am | by Ryan Bushey, Digital Editor | Articles | Comments

University of Oxford scientists have developed a gene therapy that has shown promise in treating choroideremia.


Experimental Alzheimer's Drug Reverses Disease's Genetic Changes

May 3, 2016 10:07 am | by Rockefeller University | News | Comments

In new research described recently in Molecular Psychiatry, a team led by Ana Pereira, instructor in clinical medicine in Bruce McEwen's laboratory, found that the drug, riluzole, is capable of reversing key genetic changes associated with these conditions.


Discovering Molecular Mechanism for Generating Specific Antibody Responses

May 3, 2016 9:45 am | by La Jolla Institute for Allergy and Immunology | News | Comments

Researchers identified a key signal that drives the commitment of immature Tfh cells into fully functional Tfh cells and thus driving the step-by-step process that results in a precisely tailored and effective immune response.


Open Access to Potential New Drug Target for Bowel Cancer

May 3, 2016 9:07 am | by Monash University | News | Comments

International researchers have discovered a protein that may be crucial in the development of 90 per cent of colon cancers, and may also be involved in the causation of several other cancers, including breast and liver cancers.


Why Big Pharma Firms Want to Buy Medivation

May 3, 2016 9:06 am | by Ryan Bushey, Digital Editor | Articles | Comments

A small biotechnology company is attracting significant buyout interest from a slew of big drug makers. 


Cancer Drugs Tested with Flawed Time-based Method, Says Vanderbilt Study

May 3, 2016 8:56 am | by Seth Augenstein, Digital Reporter | News | Comments

The in vitro method of testing cancer drugs on tumor cells is based on observing the rate of growth or death in the cells after set time frames, mostly 24 hours or 72 hours. A team has developed a new metric that could eliminate waste and better target the most promising drugs.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.